Literature DB >> 14761963

Positive regulation of apoptosis signal-regulating kinase 1 by hD53L1.

Sayeon Cho1, Hyung-Mun Ko, Jeong-Min Kim, Jung-A Lee, Jae-Eun Park, Mi-Sun Jang, Sung Goo Park, Do Hee Lee, Seong-Eon Ryu, Byoung-Chul Park.   

Abstract

Apoptosis signal-regulating kinase 1 (ASK1) is a mitogen-activated protein kinase kinase kinase family member that plays a central role in cytokine- and stress-induced apoptosis by activating c-Jun N-terminal kinase and p38 signaling cascades. ASK1-induced apoptotic activity is up-regulated by two cellular factors, Daxx and TRAF2, through direct protein-protein interactions. Daxx and TRAF2 are death receptor-associated proteins in Fas and tumor necrosis factor-alpha pathways, respectively. Recent studies suggest that calcium signaling may regulate ASK1 pathway. Here we report that human D53L1, a member of the tumor protein D52 family involved in cell proliferation and calcium signaling, up-regulates the ASK1-induced apoptosis. The human D53L1 physically interacts with the C-terminal regulatory domain of ASK1 and promotes ASK1-induced apoptotic activity by activating caspase signaling in mammalian cells. In luciferase reporter assays, hD53L1 activates c-Jun N-terminal kinase-mediated transactivation in the presence of ASK1. Expression of hD53L1 enhances autophosphorylation and kinase activity of ASK1 but has no effect on ASK1 oligomerization that is necessary for kinase activity and on binding of ASK1 to MKK6, a downstream factor of ASK1. Taken together, these results suggest that activation of ASK1 by hD53L1 may provide a novel mechanism for ASK1 regulation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14761963     DOI: 10.1074/jbc.M305758200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Positive regulation of apoptosis signal-regulating kinase 1 by dual-specificity phosphatase 13A.

Authors:  Jae Eun Park; Byoung Chul Park; Hyun-A Kim; Mina Song; Sung Goo Park; Do Hee Lee; Hyeoung-Joon Kim; Hyung-Kyoon Choi; Jong-Tae Kim; Sayeon Cho
Journal:  Cell Mol Life Sci       Date:  2010-04-01       Impact factor: 9.261

2.  Cell cycle-dependent Cdc25C phosphatase determines cell survival by regulating apoptosis signal-regulating kinase 1.

Authors:  Y-C Cho; J E Park; B C Park; J-H Kim; D G Jeong; S G Park; S Cho
Journal:  Cell Death Differ       Date:  2015-01-30       Impact factor: 15.828

3.  SUMO-1 represses apoptosis signal-regulating kinase 1 activation through physical interaction and not through covalent modification.

Authors:  Yun-Suk Lee; Moon-Sun Jang; Jong-Soo Lee; Eui-Ju Choi; Eunhee Kim
Journal:  EMBO Rep       Date:  2005-10       Impact factor: 8.807

4.  Embryonic atrazine exposure elicits proteomic, behavioral, and brain abnormalities with developmental time specific gene expression signatures.

Authors:  Katharine A Horzmann; Leeah S Reidenbach; Devang H Thanki; Anna E Winchester; Brad A Qualizza; Geoffrey A Ryan; Kaitlyn E Egan; Victoria E Hedrick; Tiago J P Sobreira; Samuel M Peterson; Gregory J Weber; Sara E Wirbisky-Hershberger; Maria S Sepúlveda; Jennifer L Freeman
Journal:  J Proteomics       Date:  2018-07-20       Impact factor: 4.044

5.  Identification of novel tumor suppressor genes down-regulated in recurrent nasopharyngeal cancer by DNA microarray.

Authors:  Zhenxiao Huang; Wenfeng Li; Sen Lin; Xiaobi Fang; Chunhong Zhang; Zhisu Liao
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2011-12-04

6.  Tumor protein D52 expression and Ca2+-dependent phosphorylation modulates lysosomal membrane protein trafficking to the plasma membrane.

Authors:  Diana D H Thomas; Christina L Martin; Ning Weng; Jennifer A Byrne; Guy E Groblewski
Journal:  Am J Physiol Cell Physiol       Date:  2009-12-23       Impact factor: 4.249

7.  Clarification of the molecular pathway of Taiwan local pomegranate fruit juice underlying the inhibition of urinary bladder urothelial carcinoma cell by proteomics strategy.

Authors:  Ting-Feng Wu; Li-Ting Hsu; Bo-Xian Tsang; Li-Chien Huang; Wan-Yin Shih; Li-Yi Chen
Journal:  BMC Complement Altern Med       Date:  2016-03-09       Impact factor: 3.659

Review 8.  Clinical Potential of Fruit in Bladder Cancer Prevention and Treatment.

Authors:  Paulina Wigner; Michał Bijak; Joanna Saluk-Bijak
Journal:  Nutrients       Date:  2022-03-08       Impact factor: 5.717

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.